Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

Summary

The purpose of this study is to determine whether a larger dose of the aldosterone antagonist spironolactone combined with a lower dose of an ACE inhibitor is more effective in reverse left ventricular remodeling in severe congestive heart failure in patients with nonischemic cardiomyopathy.

Timeline

Start

2005-09

Primary completion

—

Completion

2009-09

Drugs

Indications